Potomac Capital Management’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $2.06M | Buy |
1,481,742
+26,742
| +2% | +$37.2K | 2.39% | 11 |
|
|
2023
Q3 | $2.04M | Buy |
1,455,000
+405,100
| +39% | +$567K | 2.6% | 13 |
|
|
2023
Q2 | $1.93M | Buy |
1,049,900
+269,391
| +35% | +$496K | 1.98% | 14 |
|
|
2023
Q1 | $1.9M | Buy |
780,509
+211,509
| +37% | +$514K | 1.99% | 14 |
|
|
2022
Q4 | $814K | Buy |
569,000
+9,500
| +2% | +$13.6K | 0.95% | 31 |
|
|
2022
Q3 | $1.25M | Hold |
559,500
| – | – | 1.43% | 17 |
|
|
2022
Q2 | $1.16M | Buy |
559,500
+62,695
| +13% | +$130K | 1.34% | 21 |
|
|
2022
Q1 | $1.44M | Buy |
496,805
+288,805
| +139% | +$838K | 1.24% | 22 |
|
|
2021
Q4 | $668K | Buy |
+208,000
| New | +$668K | 0.59% | 41 |
|